Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cidara Thera (NQ: CDTX )

1.210 -0.070 (-5.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,263,538
Open 1.230
Bid (Size) 1.210 (4)
Ask (Size) 1.240 (8)
Prev. Close 1.280
Today's Range 1.150 - 1.350
52wk Range 0.4000 - 1.600
Shares Outstanding 49,506,268
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
From Melinta Therapeutics, LLC
Via Business Wire

Performance

YTD
+61.33%
+61.33%
1 Month
+82.97%
+82.97%
3 Month
+85.04%
+85.04%
6 Month
+65.75%
+65.75%
1 Year
+55.13%
+55.13%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Looking Into Cidara Therapeutics's Return On Capital Employed
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2022
From Cidara Therapeutics, Inc.
Via Globe NewsWire
Cidara's Lead Antifungal Candidate Goes Under Priority FDA Review
Via Benzinga
Recap: Cidara Therapeutics Q2 Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Cidara Therapeutics Receives $11.1 Million Milestone Payment from Mundipharma
From Cidara Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
Via Benzinga
With FDA Submission, Cidara Therapeutics Inks US Pact For Bloodstream Infection Candidate
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Short Volatility Alert: Cidara Therapeutics, Inc.
Via Benzinga
Short Volatility Alert: Cidara Therapeutics, Inc.
Via Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Cidara Pursues FDA Approval For Bloodstream Infections Candidate
Via Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.